What dose of Mounjaro is most effective for weight loss?

The dose-response picture: what the trial data tells you

SURMOUNT-1 enrolled 2,539 adults with obesity and ran for 72 weeks. The results showed a clear gradient: average weight loss at 5mg was around 15%, at 10mg around 19.5%, and at 15mg around 20–21%. Those figures come from the SURMOUNT-1 paper published in the New England Journal of Medicine. So yes, the most effective dose of Mounjaro in head-to-head trial arms was 15mg. That is as factual an answer as the evidence allows.

What the headline numbers don't show is the spread. Some participants lost considerably more than the average at 10mg; others lost less than the average at 15mg. Averages describe populations, not individual responses. The question of which dose is most effective for a given person is genuinely clinical, it depends on how well the current dose is working and how the side-effect profile is being tolerated.

One misconception worth letting go gently: a lot of people assume that if they aren't on 15mg they are somehow undertreated. The evidence does not support that framing. Stopping at a lower dose because it is working well and sitting comfortably is not a failure, it is the point of titration-based prescribing.

Why the starting dose exists and how the stepping-up process works

Treatment begins at 2.5mg. The job of that first pen is to settle your system into the medicine, not to produce the bulk of your weight loss. Nausea and other gastrointestinal effects are most likely to surface at the start and after each dose increase, so the schedule is deliberately gradual. As the NHS tirzepatide guidance makes clear, doses are increased roughly every four weeks under prescriber supervision.

Moving from 2.5mg to 5mg, then to 7.5mg and beyond, your prescriber is watching two things: are you losing weight at the current dose, and are you tolerating it? If the answer to both is yes, there is often no clinical reason to rush upward. 5mg has its own evidence base, and a meaningful number of people find it hits a productive balance between effect and tolerability.

Side effects are worth naming plainly here. Nausea, loose stools, constipation, reflux and fatigue are the most commonly reported, and they tend to be most noticeable in the days after a dose change. If you want a fuller picture of what to expect at the beginning, the side-effect profile at 2.5mg is a sensible starting point before titration begins. The general pattern is that effects ease once your body has adjusted to a given level.

What factors shape the most effective dose for you personally

There is no universal answer. A prescriber's job is to weigh several things together: your current weight and BMI, how much weight you have lost at the current dose, how long you have been on it, any side effects you're managing, and any medicines or conditions that affect the clinical picture. Mounjaro's UK licence covers adults with a BMI of 30 or above, or 27 and above alongside a weight-related condition; but licence eligibility and optimal individual dose are different questions.

Cost is also a reality. Mounjaro pricing in the UK rises with dose, something worth understanding before treatment starts, so that decisions about titration pace are made on clinical grounds rather than financial surprise. A transparent service spells this out upfront. Some people choose to stay at an intermediate dose partly for that reason, and a good prescriber will not push escalation for its own sake.

What none of this can be settled by is a search result. The combination of factors above is exactly what a clinical assessment is for. If you are already on treatment and wondering whether to move up, that is a question for your prescriber, using your actual data, weight recorded, dose tolerated, and any relevant health changes. Our clinical team reviews every repeat order before any dose change, which is how it should work.

Putting this together: a practical frame for the decision

If you are deciding whether to start Mounjaro or trying to understand how the dose ladder works, the short version is this. The 15mg dose produced the strongest average results in clinical trials. The dose that is most effective for you is the highest one you tolerate that continues to produce meaningful progress, and that may well be 10mg, 7.5mg, or even 5mg. 2.5mg alone is rarely where sustained results sit, but it is where the process must start.

Titration is not a race. It is a structured clinical dialogue between you and your prescriber, run over months. NICE's appraisal of tirzepatide (TA1026) notes that if less than 5% body weight is lost after six months at the highest tolerated dose, continuing treatment should be reviewed. That is a useful reference point: if the medicine is not working at a given dose, escalating or stopping is a clinical conversation, not a self-managed choice.

Thinking about starting? Check your eligibility and begin your free consultation, a real prescriber reviews your answers the same day.